HSP27 inhibitor J2
Modify Date: 2024-01-09 13:39:33
HSP27 inhibitor J2 structure
|
Common Name | HSP27 inhibitor J2 | ||
|---|---|---|---|---|
| CAS Number | 2133499-85-9 | Molecular Weight | 264.30 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C13H12O4S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of HSP27 inhibitor J2HSP27 inhibitor J2 (J2) is a HSP27 inhibitor, which significantly induces abnormal HSP27 dimer formation and inhibits a production of HSP27 giant polymers, thereby having an effect of inhibiting a chaperone function of the HSP27 and reducing a cell protection function thereof. HSP27 inhibitor J2 (J2) remarkably enhances the antiproliferative activity of 17-AAG and sensitizes cisplatin-induced lung cancer cell growth inhibition[1][2]. |
| Name | HSP27 inhibitor J2 |
|---|
| Description | HSP27 inhibitor J2 (J2) is a HSP27 inhibitor, which significantly induces abnormal HSP27 dimer formation and inhibits a production of HSP27 giant polymers, thereby having an effect of inhibiting a chaperone function of the HSP27 and reducing a cell protection function thereof. HSP27 inhibitor J2 (J2) remarkably enhances the antiproliferative activity of 17-AAG and sensitizes cisplatin-induced lung cancer cell growth inhibition[1][2]. |
|---|---|
| Related Catalog | |
| Target |
HSP27[2] |
| References |
[2]. Younghwa Na, et al. Methods for treating pulmonary fibrosis using chromenone derivatives. |
| Molecular Formula | C13H12O4S |
|---|---|
| Molecular Weight | 264.30 |
| Storage condition | -20°C |